In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine
暂无分享,去创建一个
[1] D. Mazel,et al. Antibiotics, Present and Future , 1999 .
[2] M. Schlitzer,et al. Antibiotics in malaria therapy and their effect on the parasite apicoplast. , 2010, Current molecular medicine.
[3] R. Piper,et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. , 1993, The American journal of tropical medicine and hygiene.
[4] Lucélia Magalhães da Silva,et al. Tigecycline: A Review of Properties, Applications, and Analytical Methods , 2010, Therapeutic drug monitoring.
[5] W. A. Khan,et al. Antimalarial Activity of Tigecycline, a Novel Glycylcycline Antibiotic , 2009, Antimicrobial Agents and Chemotherapy.
[6] D. Fidock,et al. In Vitro Efficacy, Resistance Selection, and Structural Modeling Studies Implicate the Malarial Parasite Apicoplast as the Target of Azithromycin* , 2007, Journal of Biological Chemistry.
[7] M. Schlitzer,et al. Telithromycin and Quinupristin-Dalfopristin Induce Delayed Death in Plasmodium falciparum , 2007, Antimicrobial Agents and Chemotherapy.
[8] R. Kast. Minocycline in cerebral malaria , 2008, Journal of Neuroscience Research.
[9] A. Magill,et al. Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis , 2011, The American journal of tropical medicine and hygiene.
[10] B. Tekwani,et al. Synthesis and Antimalarial Activities of Cyclen 4-Aminoquinoline Analogs , 2009, Antimicrobial Agents and Chemotherapy.
[11] L. C. Koontz,et al. Plasmodium berghei: development of resistance to clindamycin and minocycline in mice. , 1976, Experimental parasitology.
[12] Nobhojit Roy,et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.
[13] K. Matuschewski,et al. Natural Immunization Against Malaria: Causal Prophylaxis with Antibiotics , 2010, Science Translational Medicine.
[14] P. Rosenthal,et al. Multiple Antibiotics Exert Delayed Effects against the Plasmodium falciparum Apicoplast , 2007, Antimicrobial Agents and Chemotherapy.
[15] Daniel S. Terry,et al. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis , 2013, Proceedings of the National Academy of Sciences.
[16] H. R. Salgado,et al. Tigecycline: a review of properties, applications, and analytical methods , 2010 .
[17] P. Rosenthal. The interplay between drug resistance and fitness in malaria parasites , 2013, Molecular microbiology.
[18] P. Schlagenhauf,et al. Risk factors associated with malaria deaths in travellers: a literature review. , 2015, Travel medicine and infectious disease.
[19] A. MacGowan,et al. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. , 2006, The Journal of antimicrobial chemotherapy.
[20] C. Obonyo,et al. Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis , 2012, Malaria Journal.
[21] B. Tekwani,et al. Growth, Drug Susceptibility, and Gene Expression Profiling of Plasmodium falciparum Cultured in Medium Supplemented with Human Serum , 2007, Journal of biomolecular screening.
[22] E. Klein. Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread. , 2013, International journal of antimicrobial agents.
[23] B. Mordmüller,et al. In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon. , 2010, International journal of antimicrobial agents.
[24] P. Magnussen,et al. Antibiotic use among patients with febrile illness in a low malaria endemicity setting in Uganda , 2011, Malaria Journal.
[25] D. Terlouw,et al. Azithromycin for treating uncomplicated malaria. , 2011, The Cochrane database of systematic reviews.
[26] J. Gut,et al. In Vitro and In Vivo Antimalarial Efficacies of Optimized Tetracyclines , 2013, Antimicrobial Agents and Chemotherapy.
[27] David S. Roos,et al. A plastid organelle as a drug target in apicomplexan parasites , 1997, Nature.
[28] C. Wongsrichanalai,et al. Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[29] S. Briolant,et al. Plasmodium falciparum proteome changes in response to doxycycline treatment , 2010, Malaria Journal.